🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Idiopathic Pulmonary Fibrosis(IPF)

Inspiratory Effort Assessed Through Nasal Pressure Measurement in Patients With Idiopathic Pulmonary Fibrosis NCT05310669n/a1 site📍 Modena University of Modena and Reggio Emilia · Tests: Nasal pressure assessment Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies NCT01776398n/a1 site📍 New York Weill Medical College of Cornell University AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF NCT07194382Phase 249 sites📍 Camperdown📍 Kingswood📍 New Lambton Heights Avalyn Pharma Inc. · Tests: AP02, Placebo Pilot Study of Nitrate-rich Beetroot Juice Supplementation in Patients With Idiopathic Pulmonary Fibrosis (IPF) NCT06488638NA1 site📍 Southampton University Hospital Southampton NHS Foundation Trust · Tests: nitrate-rich beetroot juice (70ml with approx. 400 mg nitrate) twice a day for 3 days P4O2 ILD Extension NCT06644144n/a1 site📍 Amsterdam Amsterdam UMC, location VUmc · Tests: No Interventions Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases NCT06189820Phase 21 site📍 Brussels Erasme University Hospital · Tests: FAPI PET/CT Validation of the C-mo System - Cough Monitoring NCT05989698NA8 sites📍 Alfena📍 Amadora📍 Aveiro Cough Monitoring Medical Solutions · Tests: C-mo System Dose-Escalation Study of Artesunate Patients With IPF NCT05988463Phase 11 site📍 Stanford Joseph C. Wu · Tests: Artesuante, Placebo capsules Effects of Pulmonary Diseases and Their Treatment on Cardiac Function NCT05042219n/a1 site📍 Aachen Ayham Daher · Tests: Cardiac MRI Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis NCT07230288Phase 257 sites📍 Birmingham📍 Dothan📍 Kissimmee AbbVie · Tests: ABBV-142, Placebo for ABBV-142 Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets NCT07671911Phase 322 sites📍 Newport Beach📍 Palm Springs📍 Redding Trevi Therapeutics · Tests: NAL ER, Placebo Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases. NCT07466420NA1 site📍 Heraklion Katerina M. Antoniou · Tests: Quercetin (dietary supplement), Usual treatment A Phase IIb Study to Evaluate AZD8965 in Participants With IPF. NCT07652658Phase 2195 sites📍 Birmingham📍 Phoenix📍 Phoenix AstraZeneca · Tests: Placebo for AZD8965, AZD8965 low dose, AZD8965 medium dose, AZD8965 high dose Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis NCT07299695Phase 31 site📍 Pátrai Argyrios Tzouvelekis · Tests: Intravenous immunoglobulin (IVIG), Usual treatment A Study of the Natural Progression of Interstitial Lung Disease (ILD) NCT00470327n/a1 site📍 Chicago University of Chicago Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole NCT04965298Phase 357 sites📍 Norwich📍 Aberdeen📍 Antrim Norfolk and Norwich University Hospitals NHS Foundation Tru… · Tests: Lansoprazole, Matched placebo Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF) NCT07284602Phase 318 sites📍 Palm Spring📍 Redding📍 Hialeah PureTech · Tests: Deupirfenidone, Pirfenidone (PFD) Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF) NCT05571059Phase 220 sites📍 La Mesa📍 San Francisco📍 Farmington Cumberland Pharmaceuticals · Tests: Ifetroban Sodium, Placebo Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF NCT07082842Phase 31 site📍 Beijing Sunshine Lake Pharma Co., Ltd. · Tests: HEC585, Placebo, Pirfenidone A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers. NCT06267183EARLY Phase 11 site📍 Shanghai Shanghai Synvida Biotechnology Co.,Ltd. · Tests: SV001, Placebo Small Airways Disease Functional Assessment in Idiopathic Pulmonary Fibrosis (SWIFT-IPF) NCT07312305n/a2 sites📍 Milan📍 Milan University of Milan A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary Fibrosis NCT07121413Phase 212 sites📍 Chengdu📍 Guangzhou📍 Hangzhou Shanghai Synvida Biotechnology Co.,Ltd. · Tests: SV001, Placebo Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF) NCT00373841n/a1 site📍 Pittsburgh University of Pittsburgh Jin-shui Huan-xian Formula for Retarding the Decline of Pulmonary Function in IPF NCT06914713NA1 site📍 Zhengzhou Henan University of Traditional Chinese Medicine · Tests: Jin-shui Huan-xian granule, Jin-shui Huan-xian granule placebo Radiologic Features of Rheumatoid Arthritis Interstitial Lung Disease at Chest High Resolution Computed Tomography NCT07174102n/a5 sites📍 Prague📍 Ferrara📍 Modena Azienda Unita Sanitaria Locale di Piacenza · Tests: High resolution computed tomography Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis NCT06567717Phase 21 site📍 Los Angeles Cedars-Sinai Medical Center · Tests: Zinc, Placebos for zinc and nicotinamide riboside, Nicotinamide riboside A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis NCT06968845Phase 248 sites📍 Birmingham📍 Los Angeles📍 Los Angeles Rein Therapeutics · Tests: LTI-03, Dry Powder Inhaler, Placebo The Genetics of Pulmonary Fibrosis NCT03478553n/a1 site📍 Aurora University of Colorado, Denver · Tests: Blood draw, Questionnaire Photon-counting CT Scan vs Standard HRCT Scan in the Identification of Idiopathic Pulmonary Fibrosis NCT07790614n/a1 site📍 Rozzano Istituto Clinico Humanitas · Tests: Photon counting CT RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses NCT07002034Phase 232 sites📍 Birmingham📍 Tucson📍 San Diego Reunion Neuroscience Inc · Tests: RE104 for Injection
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy